Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)
At a regularly scheduled meeting of the board of directors (the "Board") of
KYTHERA Biopharmaceuticals, Inc. (the "Company") held on December 11, 2012,
Hironori Hozoji informed the Company of his intention to resign from the Board
effective December 14, 2012. Mr. Hozoji was originally elected to the Board in
May 2008 in connection with an investment in the Company by JAFCO Co., Ltd., a
venture capital firm in Tokyo, Japan ("JAFCO"). Mr. Hozoji's resignation was at
the request of JAFCO, where he currently serves as an Investment Officer at
JAFCO Life Science Investments in San Diego, and was not a result of any
disagreement with the Company.
Add
KYTH to Portfolio
Set Alert
Email to a
Friend